Cargando…

Proteomic alterations of HDL in youth with type 1 diabetes and their associations with glycemic control: a case–control study

BACKGROUND: Patients with type 1 diabetes (T1DM) typically have normal or even elevated plasma high density lipoprotein (HDL) cholesterol concentrations; however, HDL protein composition can be altered without a change in cholesterol content. Alteration of the HDL proteome can result in dysfunctiona...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gourgari, Evgenia, Ma, Junfeng, Playford, Martin P., Mehta, Nehal N., Goldman, Radoslav, Remaley, Alan T., Gordon, Scott M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437869/ https://www.ncbi.nlm.nih.gov/pubmed/30922315 http://dx.doi.org/10.1186/s12933-019-0846-9

Ejemplares similares

3065 A1BG and ITIH4 proteins are upregulated on HDL of youth with type 1 diabetes and correlate with glycemic control
por: Gourgari, Evgenia, et al.
Publicado: (2019)

Effect of metformin on the high‐density lipoprotein proteome in youth with type 1 diabetes
por: Gourgari, Evgenia, et al.
Publicado: (2021)

Low cholesterol efflux capacity and abnormal lipoprotein particles in youth with type 1 diabetes: a case control study
por: Gourgari, Evgenia, et al.
Publicado: (2018)

Exenatide Improves HDL Particle Counts and Size Distribution in Patients With Long-standing Type 1 Diabetes
por: Gourgari, Evgenia A., et al.
Publicado: (2017)

Changes in HDL cholesterol, particles, and function associate with pediatric COVID-19 severity
por: Mietus-Snyder, Michele, et al.
Publicado: (2022)

HDL subclass proteomic analysis and functional implication of protein dynamic change during HDL maturation
por: Zhang, Yuling, et al.
Publicado: (2019)

Complex association of apolipoprotein E–containing HDL with coronary artery disease burden in cardiovascular disease
por: Sorokin, Alexander V., et al.
Publicado: (2022)

The effect of sodium‐glucose cotransporter 2 inhibitors and glucagon‐like peptide 1 agonists on cardiovascular disease in patients with type 2 diabetes
por: Dey, Amit K., et al.
Publicado: (2019)

Association of Race and Ethnicity With Glycemic Control and Hemoglobin A(1c) Levels in Youth With Type 1 Diabetes
por: Kahkoska, Anna R., et al.
Publicado: (2018)

Alterations of HDL’s to piHDL’s Proteome in Patients with Chronic Inflammatory Diseases, and HDL-Targeted Therapies
por: Vyletelová, Veronika, et al.
Publicado: (2022)

Genetic control of the mouse HDL proteome defines HDL traits, function, and heterogeneity
por: Pamir, Nathalie, et al.
Publicado: (2019)

Effect of niacin monotherapy on high density lipoprotein composition and function
por: Gordon, Scott M., et al.
Publicado: (2020)

Testosterone replacement in hypogonadal men alters the HDL proteome but not HDL cholesterol efflux capacity
por: Rubinow, Katya B., et al.
Publicado: (2012)

The Association Between Reduction in Inflammation and Changes in Lipoprotein Levels and HDL Cholesterol Efflux Capacity in Rheumatoid Arthritis
por: Liao, Katherine P., et al.
Publicado: (2015)

Dietary Behaviors Predict Glycemic Control in Youth With Type 1 Diabetes
por: Mehta, Sanjeev N., et al.
Publicado: (2008)

Cardiac structure and function are altered in type 2 diabetes and Non-alcoholic fatty liver disease and associate with glycemic control
por: Cassidy, Sophie, et al.
Publicado: (2015)

HDL functionality in type 1 diabetes: enhancement of cholesterol efflux capacity in relationship with decreased HDL carbamylation after improvement of glycemic control
por: Denimal, Damien, et al.
Publicado: (2022)

Effects of sitagliptin beyond glycemic control: focus on quality of life
por: Sakamoto, Yoshiko, et al.
Publicado: (2013)

Lipoprotein (a) in type 2 diabetes mellitus: Relation to LDL:HDL ratio and glycemic control
por: Singla, Seema, et al.
Publicado: (2009)

Racial and Ethnic Disparities in Glycemic Control Among Insured US Adults
por: Zakaria, Nora I., et al.
Publicado: (2023)

Alterations in lipid transfers to HDL associated with the presence of coronary artery disease in patients with type 2 diabetes mellitus
por: Sprandel, Marilia C O, et al.
Publicado: (2015)

Evaluation of monocyte to HDL cholesterol ratio and other inflammatory markers in patients with psoriasis()()
por: Sirin, Mumtaz Cem, et al.
Publicado: (2020)

Impact of glycemic control on aortic stiffness, left ventricular mass and diastolic longitudinal function in type 2 diabetes mellitus
por: Kozakova, Michaela, et al.
Publicado: (2017)

Relapsing-remitting multiple sclerosis patients display an altered lipoprotein profile with dysfunctional HDL
por: Jorissen, Winde, et al.
Publicado: (2017)

Poor Glycemic Control Is an Independent Risk Factor for Low HDL Cholesterol in Patients With Type 2 Diabetes
por: Gatti, Alessandra, et al.
Publicado: (2009)

Does glycemic control reverse dispersion of ventricular repolarization in type 2 diabetes?
por: Miki, Takayuki, et al.
Publicado: (2014)

Glycemic Control Trajectories and Risk of Perinatal Complications Among Individuals With Gestational Diabetes
por: Chehab, Rana F., et al.
Publicado: (2022)

Association between glycemic control and risk of venous thromboembolism in diabetic patients: a nested case–control study
por: R. Charlier, Sarah H., et al.
Publicado: (2022)

Ciprofibrate therapy in patients with hypertriglyceridemia and low high density lipoprotein (HDL)-cholesterol: greater reduction of non-HDL cholesterol in subjects with excess body weight (The CIPROAMLAT study)
por: Aguilar-Salinas, Carlos A, et al.
Publicado: (2004)

Hemorheological and Glycemic Parameters and HDL Cholesterol for the Prediction of Cardiovascular Events
por: Cho, Sung Woo, et al.
Publicado: (2016)

Altered HDL proteome predicts incident CVD in chronic kidney disease patients
por: Shao, Baohai, et al.
Publicado: (2021)

The Triglyceride/HDL Ratio and Triglyceride Glucose Index as Predictors of Glycemic Control in Patients with Diabetes Mellitus Type 2
por: Babic, Nermina, et al.
Publicado: (2019)

Effects of α-Cyclodextrin on Cholesterol Control and Hydrolyzed Ginseng Extract on Glycemic Control in People With Prediabetes: A Randomized Clinical Trial
por: Bessell, Erica, et al.
Publicado: (2020)

Effects of Carbohydrate and Dietary Fiber Intake, Glycemic Index and Glycemic Load on HDL Metabolism in Asian Populations
por: Yanai, Hidekatsu, et al.
Publicado: (2014)

Influencing factors on cardiac structure and function beyond glycemic control in patients with type 2 diabetes mellitus
por: Ichikawa, Ryoko, et al.
Publicado: (2013)

Inflammatory biomarkers in type 2 diabetic patients: effect of glycemic control and impact of ldl subfraction phenotype
por: Vinagre, Irene, et al.
Publicado: (2014)

Possible effects of glimepiride beyond glycemic control in patients with type 2 diabetes: a preliminary report
por: Nakamura, Ikuko, et al.
Publicado: (2014)

Variant rs10911021 that associates with coronary heart disease in type 2 diabetes, is associated with lower concentrations of circulating HDL cholesterol and large HDL particles but not with amino acids
por: Beaney, Katherine E., et al.
Publicado: (2016)

Genetic Control of Genomic Alterations Induced in Yeast by Interstitial Telomeric Sequences
por: Moore, Anthony, et al.
Publicado: (2018)

Quantifying the HDL proteome by mass spectrometry: how many proteins truly associate with HDL?
por: Marsche, Gunther
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_maln41e8igeiel3o4hp7cvao1c